Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3

뉴스 본문을 불러오고 있어요.

Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3 | 웨이프 WAPE

Anteris Technologies To Present First 30-Day Clinical And Hemodynamic Outcomes For Its Medium-Size DurAVR Transcatheter Heart Valve At The Transcatheter Cardiovascular Therapeutics Conference, October 31-November 3

기사 요약

관련 종목

댓글 —